Image

Transition to Ambulatory Bariatric Surgery (TABS) Trial

Transition to Ambulatory Bariatric Surgery (TABS) Trial

Recruiting
25-55 years
All
Phase N/A

Powered by AI

Overview

This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.

Description

This pragmatic, parallel, randomized, open-label trial aims to determine the safety and feasibility of same day discharge (SDD) for bariatric surgery including sleeve gastrectomy and gastric bypass. Investigators will investigate the frequency of 7-day emergency department visits with SDD after bariatric surgery (Aim 1). In addition, the investigators will compare total 30-day charges between participants who undergo same day discharge versus those receive post-operative hospital admission (Aim 2).

Eligibility

Inclusion Criteria:

  • BMI ≤ 60 kg/m2
  • Primary Sleeve gastrectomy or Gastric Bypass,
  • Undergoing bariatric surgery at sponsor site

Exclusion Criteria:

  • Type 1 Diabetes
  • Myocardial Infarction
  • Unstable Angina or Heart Failure
  • Prior Stroke
  • Solid organ transplantation
  • Systemic glucocorticoid prior 28 days
  • Severe Obstructive Sleep Apnea
  • Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90)
  • Untreated Hyperthyroidism
  • Chronic Kidney Disease (EGFR \< 60)
  • Current anticoagulant use,
  • Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%)
  • Chronic opioid use
  • Insulin dependence.
  • Need for extended venous thromboembolic event prophylaxis,
  • \> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery)
  • Patient lives \> 130 miles from the hospital.
  • Tobacco use in last 12 months
  • Desire to become pregnant or active pregnancy
  • Prisoners
  • Unable or unwilling to follow-up
  • Unable to understand or provide consent

Study details
    Obesity and Obesity-related Medical Conditions
    Bariatric Surgery

NCT07011628

Vanderbilt University Medical Center

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.